Proposed global prognostic score for systemic mastocytosis: a retrospective prognostic modelling study.

doi:10.1016/S2352-3026(20)30400-2

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Proposed global prognostic score for systemic mastocytosis: a retrospective prognostic modelling study.

The Lancet. Haematology - 1 Mar 2021

Muñoz-González Javier I, Álvarez-Twose Iván, Jara-Acevedo María, Zanotti Roberta, Perkins Cecelia, Jawhar Mohamad, Sperr Wolfgang R, Shoumariyeh Khalid, Schwaab Juliana, Greiner Georg, Henriques Ana, Caldas Carolina, Fernández-Giménez Carlos, Sánchez-Muñoz Laura, Mayado Andrea, Pérez-Pons Alba, Schmitt-Graeff Annette, Duyster Justus, Tanasi Ilaria, Olivieri Francesco, Mora-Casterá Elvira, Luna Irene, Senent Leonor, Bañas Maria-Helena, Nuñez-García Amanda, Jurado-Chacón Manuel, Martín-Sánchez Guillermo, Colado Enrique, Xicoy Blanca, Gener-Ricós Georgina, Gotlib Jason, Bonadonna Patrizia, Reiter Andreas, Valent Peter, García-Montero Andrés C, Orfao Alberto

Abstract excerpt

BACKGROUND: Several risk stratification models have been proposed in recent years for systemic mastocytosis but have not been directly compared. Here we designed and validated a risk stratification model for progression-free survival (PFS) and overall survival (OS) in systemic mastocytosis on the basis of all currently available prognostic factors, and compared its predictive capacity for patient outcome with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Alkaline Phosphatase

Share to Core Binding Factor Alpha 2 Subunit

Share to Hemoglobins

Share to Kaplan-Meier Estimate

Share to Mastocytosis, Systemic

Share to Progression-Free Survival

Share to Repressor Proteins

Share to Serine-Arginine Splicing Factors

Source

Open in PubMed

Identifiers

PMID: 33508247
DOI: 10.1016/S2352-3026(20)30400-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Proposed global prognostic score for systemic mastocytosis: a retrospective prognostic modelling study.PMID 33508247Read ↗

MARS: Mutation-Adjusted Risk Score for Advanced Systemic MastocytosisSemantic proximity Read ↗

Next-generation sequencing in systemic mastocytosis: Derivation of a mutation-augmented clinical prognostic model for survival.Semantic proximity Read ↗

Systemic mastocytosis in adults: 2015 update on diagnosis, risk stratification, and management.Semantic proximity Read ↗

Systemic mastocytosis in adults: 2013 update on diagnosis, risk stratification, and management.Semantic proximity Read ↗

Systemic Mastocytosis in Adults: 2026 Update on Diagnosis, Risk Stratification and Management.Semantic proximity Read ↗

Clinical and Molecular Diagnostic Evaluation of Systemic Mastocytosis in the South-Eastern Hungarian Population Between 2001-2013--A Single Centre Experience.Semantic proximity Read ↗

Diagnosis, progression patterns and prognostication in mastocytosis.Semantic proximity Read ↗

Importance of Adequate Diagnostic Workup for Correct Diagnosis of Advanced Systemic Mastocytosis.Semantic proximity Read ↗

Comprehensive Mastocytosis Data Analysis From A Single CenterSemantic proximity Read ↗

Cytogenetic abnormalities in systemic mastocytosis: WHO subcategory-specific incidence and prognostic impact among 348 informative cases.Semantic proximity Read ↗

Proposed European Competence Network on Mastocytosis-American Initiative in Mast Cell Diseases (ECNM-AIM) Response Criteria in Advanced Systemic Mastocytosis.Semantic proximity Read ↗

Systemic mastocytosis with an associated myeloid neoplasm: Report from the XVI European Bone Marrow Working Group Course and Workshop, Barcelona 2023.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.